Exploratory Factor Analysis (EFA) is a pivotal statistical approach that enables researchers to uncover latent structures in complex datasets, a process that is increasingly integral to higher ...
SAN DIEGO — An analysis comparing patient-level data from two recent phase 3 trials demonstrated an approximately 40% reduction in the risk for non–small cell lung cancer (NSCLC) recurrence or death ...
Effect of sitravatinib combined with PD-1 blockade on cytotoxic T-cell infiltration by M2 to M1 tumor macrophage repolarization in esophageal adenocarcinoma. This is an ASCO Meeting Abstract from the ...
ALLO-316 in advanced clear cell renal cell carcinoma (ccRCC): Updated results from the phase 1 TRAVERSE study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...
New biomarker analyses from the phase 3 KEYNOTE-522 trial provide insights into the biological factors that may influence response to pembrolizumab plus chemotherapy in early-stage triple-negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results